Phosphoinositide 3 kinase

Cat.No. Product Name Feedback Added

S2636

A66

Jul 2011
A66 is a highly specific and selective p110α inhibitor with IC50 of 32,30 and 43 nM for p110α, p110α/E545K, p110α/H1047R, respectively.
S2671

AS-252424

Aug 2011
AS-252424 is a potent and selective PI3k γ inhibitor with IC50 of 33 and 935 nM for PI3Kγ and PI3Kα, respectively.
S2681

AS-604850

Aug 2011
AS-604850 is a selective, ATP-competitive PI3Kγ inhibitor with IC50 of 0.25, >20, >20, and 4.5 µM for the human recombinant γ, δ, β, and α isoforms, respectively.
S1410

AS-605240

Jul 2010
AS-605240 is a PI3K γ inhibitor (IC50 at 8 nM).
S1462

AZD6482

Aug 2010
AZD6482 is a PI3Kβ inhibitor (IC50=0.021μM) used in antithrombotic therapy.
S1009

BEZ235 (NVP-BEZ235)

Apr 2009
BEZ235 (NVP-BEZ235) is a dual ATP-competitive phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor with an IC50 of 4, 5, 7 and 75 nM for p110α, p110γ, p110δ and p110β, respectively.
S2247

BKM120 (NVP-BKM120)

May 2011
BKM120 (NVP-BKM120) is a bioavailable specific oral pan-class I phosphatidylinositol 3-kinase (PI3K) kinase inhibitor.
S2226

CAL-101

Apr 2011
CAL-101 is a potent PI3K p110δ inhibitor with an IC50 of 65 nM.
S2682

CAY10505

Aug 2011
CAY10505 is a potent PI3Kγ inhibitor with an IC50 of 30 nM.
S2699

CH5132799 

Nov 2011
CH5132799 is a novel and selective class I PI3K inhibitor with IC50 of 0.014, 0.12, 0.5, 0.036, 5.3 and 1.6 μM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, PI3K C2β and mTOR, respectively.
S2675

D-106669

Aug 2011
D-106669 is a highly selective PI3K inhibitor with a submicromolar inhibition.
S2676

D-87503

Aug 2011
D-87503 is a potent PI3K/Akt/mTOR signaling pathway inhibitor with IC50 of 62nM and 0.76μM for PI3K and Erk2, respectively.
S1065

GDC-0941

Jun 2009
GDC-0941 is an inhibitor of Class I PI3 Kinase,p110a IC50=0.003uM,U87MG IC50=0.95μM.
S2696

GDC-0980 (RG7422) 

Nov 2011
GDC-0980 (RG7422) is a selective, dual PI3 Kinase and mTOR Kinase inhibitor with IC50 of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, respectively.
S1360

GSK1059615

Jun 2010
GSK1059615 is a pan-PI3K reversible inhibitor,IC50:PI3Kα(0.4 nM), β (0.6 nM),γ (5 nM),δ (2 nM) and mTOR(12 nM).
S2658

GSK2126458

Aug 2011
GSK2126458 is a highly potent PI3K and mTOR inhibitor with an app Ki of 19 pM for PI3K.
S1268

IC-87114

Jun 2010
IC-87114 was the first isoform-selective PI3K inhibitor : p110δ(IC50 = 0.13 µM) vs. p110α(IC50 = 200 µM), p110β(IC50 = 16 µM) and p110γ(IC50 = 61 µM).
S1105

LY294002

Aug 2009
PI3k inhibitor (cell IC50 about 10 μM) and a casein kinase II inhibitor.
S2638

NU7441

Aug 2011
NU7441 is a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor with IC50 of 0.01, 1.7 and 5 μM for DNA-PK, mTOR and PI 3-K, respectively.
S2743

PF-04691502 

Jan 2012
PF-04691502 is a potent and selective dual PI3K/mTOR inhibitor to phosphorylation of AKT T308 and AKT S473 with IC50 of 7.5 and 3.8 nM, respectively.
S1038

PI-103

Apr 2009
PI-103 is a potent, cell-permeable, ATP-competitive PI3K family members inhibitor with IC50 of 2, 8, 20, 26, 48, 83, 88, 150 nM for DNA-PK, p110α, mTORC1, PI3-KC2β, p110δ, mTORC2, p110β, and p110γ, respectively.
S2207

PIK-293

Feb 2011
PIK-293 is a PI3-K inhibitor.PIK-293 inhibit the p110α, p110β, p110δ, and p110γ with IC50 of 100uM,25uM,0.24uM,and 10uM.
S2227

PIK-294

Apr 2011
PIK-294 is a highly selective p110 inhibitor with an IC50 of 3 nM.
S1187

PIK-90

Apr 2010
PIK-90 is a PI3K inhibitor,IC50=11, 350, 18, and 58 for p110 α, β, γ and δ isoforms.
S1489

PIK-93

Sep 2010
PIK-93 is a PI4KIIIβinhibitor (IC50 at 19 nM).
S2739

PKI-402 

Nov 2011
PKI-402 is a selective, reversible, ATP-competitive, equipotent class I phosphatidylinositol 3-kinases (PI3K) inhibitor with IC50 of 1, 7, 16 and 14 nM for PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ, respectively.
S2628

PKI-587

Jul 2011
PKI-587 is a highly potent dual PI3K/mTOR kinase inhibitor with IC50 of 0.4 nM and <0.1 μM for PI3K-α and mTOR, respectively.
S2622

PP121

Jun 2011
PP121 is a multitargeted dual receptor tyrosine kinases inhibitor with IC50 of 0.052, 1.4, 0.15, 1.1, 0.06, 0.01and 0.002 μM for p110α, p110β, p110δ, p110γ, DNA-PK, mTOR and PDGFR, respectively.
S2391

Quercetin(Sophoretin)

Feb 2011
Quercetin is a PI3K and PKC inhibitor with IC50 of 3.8 μM and 15µg/ml.
S1352

TG100-115

Jun 2010
TG100–115 is a PI3K γ and -δ inhibitor (IC50 = 83 and 235 nM, respectively)
S1169

TGX-221

Mar 2010
TGX-221 is a PI3Kβ(C50=10nM).
S1118

XL147

Sep 2009
XL147 is a selective inhibitor of Class I PI3K isoforms.
S1523

XL765

Oct 2010
XL765 is a mixed mTOR/PI3k inhibitor with IC50 of 157, 39, 113, 9 and 43 nM for mTOR, p110α, β, γ and δ, respectively.
S1072

ZSTK474

Jun 2009
ZSTK474 is an inhibitor of PI3K γ(IC50 at 6 nM).
Buy Now / Print Quote

Find Multiple Products by Catalog Number

Continue
Customer's Feedback
Arnaud AUTRET, Trinity College
"I would like to confirm you that everything is perfectly fine with ABT and Obatoclax we got from your company. We confirmed their activity in vitro. We notably observed their impact in an apoptotic model and results are similar to those which have been published."

Dongfeng Chen, The Rausing Lab
"Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future."

Dr. Alexandra Segref, CECAD Cologne,Germay
"I am very satisfied with your product and costumer service. Bortezomib works very well in our assay, it is comparably cheaper than other inhibitors that we tested is more reliable for our assays. We see a great effect by using 10nM concentration."

R.B. Cambridge
"I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more."

Zhenghe John Wang Assistant Professor, Case Western Reserve University
"We have purchased LBH-589, Saha and MS-275 from you and they all worked well."

Jenny Sun
"We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility."

Yu Wang, Harvard University
"The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research."

Philip Seeman, Toronto University
"Your LY404039 compound was well synthesized, its complicated stereochemical structure confirmed by NMR spectroscopy, and was biologically excellent in acting on brain dopamine receptors."

Dung-Fang Lee
"Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells."

Latest Catalog
May 2010
Selleck
Latest
Catalog

Selleck Chemicals Catalog
| Inhibitor | Antibody | siRNA | Protein | Peptide | Cell Signal | © Copyright 2010 Selleck. All Rights Reserved.